验证数据展示
经过测试的应用
Positive WB detected in | ROS1728 cells, K-562 cells, MCF-7 cells, A431 cells |
Positive IHC detected in | human kidney tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
60244-1-Ig targets PLAA in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
经测试应用 | WB, IHC, ELISA Application Description |
经测试反应性 | human, mouse, rat |
免疫原 | PLAA fusion protein Ag3224 种属同源性预测 |
宿主/亚型 | Mouse / IgG1 |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | phospholipase A2-activating protein |
别名 | DOA1, PLA2P, PLAA, PLAP |
计算分子量 | 738 aa, 81 kDa |
观测分子量 | 75-80 kDa |
GenBank蛋白编号 | BC032551 |
基因名称 | PLAA |
Gene ID (NCBI) | 9373 |
RRID | AB_2881366 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Protein A purification |
UNIPROT ID | Q9Y263 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Phospholipase A-2-activating protein (PLAA), also named PLAP, can interact with ubiquitin and is involved in the maintenance of ubiquitin levels. PLAA contains multiple consensus domains including WD repeats, PFU domain and PUL domain. Although the function of PLAA remains unclear, ubiquitin binding of PLAA might be the central role that connects ubiquitination and degradation in ERAD. Recent finding revealed that PLAA served as a novel nociveptive mediator after incision, and its expression level is regulated by miR-203.
实验方案
Product Specific Protocols | |
---|---|
WB protocol for PLAA antibody 60244-1-Ig | Download protocol |
IHC protocol for PLAA antibody 60244-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |